Back to results
US 2023/0271966 A1Published application
Prpk inhibitors
AssigneeDana-Farber Cancer Institute, Inc.
InventorsKenneth C. Anderson, Teru Hideshima, Sirano Dhe-Paganon, Hyuk-Soo Seo, Takashi Mizutani, Tinghu Zhang
Life of this patent
Estimating the term…
Abstract
This disclosure relates to compounds of formula (I) as defined in the Specification. This disclosure also relates to methods of synthesizing the compound of formula (I) and using the compounds of formula (I) for treating a disease (e.g., cancer).
Claims18
A compound of formula (I) or a salt thereof:
- wherein
- each of R1, R2, R3, and R4, independently, is H, halo, OR, COOR, C(O)R, C(O)N(RR′), NH—S(O)2—R, N(RR′), C1-C10 alkyl, C1-C10 arylalkyl, C2-C10 alkenyl, C2-C10 alkynyl, C3-C20 cycloalkyl, C3-C20 cycloalkenyl, C1-C20 heterocycloalkyl, C1-C20 heterocycloalkenyl, aryl, or heteroaryl;
- or R1 and R2, together with the carbon atoms to which they are attached, form a group comprising a five-membered or six-membered ring;
- or R2 and R3, together with the carbon atoms to which they are attached, form a group comprising a five-membered or six-membered ring;
- or R3 and R4, together with the carbon atoms to which they are attached, form a group comprising a five-membered or six-membered ring;
- R5 is H or C1-C10 alkyl optionally substituted by aryl;
- each of C1-C10 arylalkyl, C3-Cao cycloalkyl, C3-Cao cycloalkenyl, C1-Cao heterocycloalkyl, C1-C20 heterocycloalkenyl, aryl, heteroaryl, five-membered ring, and six-membered, independently, is optionally substituted by C1-C10 alkyl, halo, OR, or COOR;
- and
- each of R and R′, independently, is H, C1-C10 alkyl, C3-Cao cycloalkyl, C3-Cao heterocycloalkyl, aryl, or heteroaryl;
- provided that when one of R1, R2, R3, and R4 is NH2, at least another of R1, R2, R3, and R4 is not H or R5 is not H;
- and when one of R1 and R4 is OH or OCH3, the other of R1 and R4 is not H, or one of R2 and R3 is not H, or R5 is not H or CH3.
8 more elements
Dependencies are inferred from the claim text.